Context Therapeutics Inc. (CNTX): Total Assets
$68.49M
As of 2025-12-31
$46.13M
As of 2026-06-30
+21.7%
3-year compound annual growth
n/m
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $68.49M | -30.2% | 2026-03-23, Balance as of period end |
| 2024-12-31 | $98.13M | +510.9% | 2026-03-23, Balance as of period end |
| 2023-12-31 | $16.06M | -57.7% | 2025-03-20, Balance as of period end |
| 2022-12-31 | $37.97M | -26.0% | 2024-03-21, Balance as of period end |
| 2021-12-31 | $51.31M | n/m | 2023-03-22, Balance as of period end |
| 2020-12-31 | $467.3K | n/a | 2022-03-23, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | 2025-12-31 | $68.49M | -30.2% |
| Spero Therapeutics, Inc. (SPRO) | 2025-12-31 | $68.92M | -37.7% |
| Werewolf Therapeutics, Inc. (HOWL) | 2025-12-31 | $69.40M | -45.3% |
| Grace Therapeutics, Inc. (GRCE) | 2026-03-31 | $66.65M | -7.4% |
| Corvus Pharmaceuticals, Inc. (CRVS) | 2025-12-31 | $71.12M | +3.2% |
| Aldeyra Therapeutics, Inc. (ALDX) | 2025-12-31 | $72.06M | -31.1% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $74.31M | -34.4% |
| Rallybio Corp (RLYB) | 2025-12-31 | $62.26M | -8.6% |
| OnKure Therapeutics, Inc. (OKUR) | 2025-12-31 | $62.12M | -45.9% |
Compare CNTX, SPRO, HOWL, GRCE side by side · Screen every company in Pharmaceutical Preparations ↗